U.S. FDA Approves IDE for Bionic Pancreas
12/3/2012
Egret Technologies congratulates its client Boston University, a leader in diabetes care research, on the FDA approval of their IDE for outpatient clinical studies using the latest bionic pancreas. This mobile-device platform, with closed loop algorithms running on the iPhone, integrating the Dexcom G4 Platinum continuous glucose monitoring (CGM) system with Tandem Diabetes t:slim infusion pumps, was developed in a multi-body partnership with Egret Technologies.
Read More »